In addition, we examined if plasma levels of factors suspected to be involved in development of pulmonary fibrosis (i.e., MMP-9, SP-D, and VEGF-A), obtained during hospital admission and after 3 months, were related to patient-reported outcome measures, as well as pulmonary function and persistent findings on chest CT. The gene discussed is MMP9; the disease is pulmonary fibrosis.